Declining Rates of Treatment-Related Mortality in Patients with Newly-diagnosed AML Given “Intense” Induction Regimens: A Report from SWOG and MD Anderson

Less-intense remission induction regimens for adults with newly-diagnosed AML aim to reduce treatment-related mortality (TRM), here defined as death within 4 weeks after starting induction therapy. This assumes that TRM rates are similar to the 15-20% observed 20 years ago. Herein we test this assum...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Leukemia
Auteurs principaux: Othus, Megan, Kantarjian, Hagop, Petersdorf, Stephen, Ravandi, Farhad, Godwin, John, Cortes, Jorge, Pierce, Sherry, Erba, Harry, Faderl, Stefan, Appelbaum, Frederick R., Estey, Elihu
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4457325/
https://ncbi.nlm.nih.gov/pubmed/23760400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.176
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires